Press release
Toxoid Vaccine Market Report 2021: By Key Players, Application, Type, Share and Forecast 2021-2027
Toxoid vaccine market is biologically inactivated forms of native toxins. The market for toxoid vaccine is projected to be growing at a CAGR of 4.3% for the forecast 2018-2023. The most commonly used toxoid is tetanus toxoid, diphtheria-derived toxoids and other proteins are used occasionally. Diphtheria toxoid is produced globally in a standard fashion, in the US, production and testing procedures are specified in the Code of Federal Regulations. Diphtheria toxoid is manufactured both by large multinational vaccine companies and by developing countries for domestic use. Boostrix and Adacel are the examples and are approved for individuals 11 to 64 years of age.A full report of Toxoid Vaccine Market is available at: https://www.omrglobal.com/industry-reports/toxoid-vaccine-market
The increasing number of reported cases of tetanus and diphtheria in developing economies is driving the growth of the market. Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. About 10% of those infected expire while a large number become incapacitated due to bone fractures. Tetanus toxoid vaccine is used for tetanus prevention by developing immunity against the pathogen causing tetanus. Initially it was developed in 1924 and has resulted in a 95% decrease in the rate of tetanus in the US and is on the World Health Organization’s list of essential medicines. The low cost of tetanus vaccine is the other reason for the market growth.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/toxoid-vaccine-market
The market restraints of the toxoid vaccine are the severe side-effects associated with toxoid vaccine which makes it less preferable. Bipolar and contractual nature of the market, falling profitability of vaccine manufacturing and lesser demands for these vaccines in the developed regions are hindering the growth of the market. In UK there were a total of 4 cases reported due to deprivation of tetanus vaccine. In US there were no reported cases of tetanus deprivation. Almost all cases of tetanus in the US are caused in people who have never been immunized or who have not had a tetanus booster shot within the preceding 10 years. However, government initiatives for vaccination programs in the developing economies will have a positive impact on the growth of the market.
The toxoid vaccine market is segmented on the basis of disease, composition, form and end-user. On the basis of disease, the market is bifurcated into tetanus, diphtheria and pertussis. On the basis of composition the market is segmented into monovalent tetanus toxoid (TT), diphtheria, tetanus, and pertussis (DtaP), diphtheria and tetanus (DT), tetanus and diphtheria (Td) and tetanus, diphtheria, and pertussis (Tdap). TaP and DT vaccines are used for age 6 years or smaller. The DTaP is formulated with inactivated polio–hepatitis B (Pediarix). Adult Td can be used to vaccinate individuals 7 years and older. Tdap vaccines are available for children between 10 and 18 years of age On the basis of enduser the market is segmented into hospitals, clinics and government organizations. Government organization is the largest segment due to the healthcare vaccinations programs initiatives.
Toxoid Vaccine Market- Segmentation
By Disease
• Tetanus
• Diptheria
• Pertusis
By Composition
• Monovalent Tetanus Toxoid (Tt)
• Diphtheria, Tetanus, And Pertussis (Dtap)
• Diphtheria And Tetanus (Dt)
• Tetanus And Diptheria (Td)
• Tetanus, Diphtheria, And Pertussis (Tdap)
By Form
• Quadrivalent
• Pentavalent
• Hexavelent
By End-User
• Hospitals
• Clinics(Vetinary)
• Governement
Toxoid Vaccine Market– Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• ASTRAZENECA PLC
• ASTELLAS PHARMA INC.
• BAYER AG
• BHARAT BIOTECH
• CEVA SANTÉ ANIMALE S.A.
• EMERGENT BIOSOLUTIONS INC.
• GLAXOSMITHKLINE PLC
• GRIFOLS S.A.
• MERCK & CO. INC. (MERCK SHARP & DOHME CORP.)
• NOVARTIS AG
• PANACEA BIOTEC LTD.
• PAXVAX INC.
• PFIZER INC.
• SANOFI PASTEUR INC.
• SINOVAC BIOTECH LTD.
• THE SERUM INSTITUTE OF INDIA LIMITED
• VIRBAC
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Toxoid Vaccine Market Report 2021: By Key Players, Application, Type, Share and Forecast 2021-2027 here
News-ID: 2524612 • Views: …
More Releases from Orion Market Research
Hematopoietic Stem Cell Transplantation Market Analysis and Forecast 2024-2031
The global hematopoietic stem cell transplantation market is anticipated to grow at a considerable CAGR during the forecast. The Major driver in the hematopoietic stem cell transplantation market is the growing network of hematopoietic stem cell transplantation organizations that have reached across the globe and have been seen by an NGO called the Worldwide Network for Blood and Marrow Transplantation Group officially affiliated with the World Health Organization. The growing…
Guidewires Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
The global guidewires market is anticipated to grow at a considerable CAGR of 4.9% during the forecast. The increasing prevalence of minimally invasive surgical practices in major regions will drive the market growth. Minimally invasive medical practices have a numerous advantages over open procedures, including shorter hospital stays, speedier patient recovery, increased operational safety and effectiveness, and lower costs. Healthcare practitioners are continually turning for alternative treatments that give patients…
Gene Therapy Products Market Will Exhibit an Impressive Expansion by 2024-2031
The global gene therapy products market is anticipated to grow at a significant CAGR during the forecast period. Gene therapy is an advanced medical treatment involving the transfer of a normal/ healthy gene to replace a defective gene in a cell. The market growth is majorly attributed owing to the growing incidences of various chronic and genetic disorders in human beings that can be cured through gene therapy. Gene therapy…
Eisenmenger Syndrome Treatment Market Will Exhibit an Impressive Expansion by 20 …
The global eisenmenger syndrome treatment market is anticipated to grow at a CAGR during the forecast period. The triad of systemic-to-pulmonary congenital cardiovascular communication, pulmonary arterial disease, and cyanosis is called Eisenmenger syndrome. The major factor that drives the market is consistent regulatory approval to the key players operating in the global market for the treatment of Eisenmenger syndrome by providing drugs, and therapy is expected to drive the market…
More Releases for Tetanus
Diphtheria, Pertussis, and Tetanus Vaccine Market
According to a new report published by Allied Market Research, titled, "Diphtheria, Pertussis, and Tetanus Vaccine Market by Product Type [DTaP (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel), Td (Decavac and Tenivac), and Tdap (Boostrix and Adacel)], Vaccine Type (Whole-Cell Vaccine and Acellular Vaccine), Age Group (Adult and Pediatric), and End User (Hospitals, Clinics, and Vaccination Centers) - Global Opportunity and Forecast, 2019-2026 ".
The Global market size of Diphtheria, Pertussis,…
Tetanus Toxoid Vaccine Market
The report for Global Tetanus Toxoid Vaccine Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance.
Market Highlights:
Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. The spasms may be very severe and even cause bone…
Tetanus-Pipeline Review H2 2018
Tetanus (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various…
Tetanus-Pipeline Review H2 2018
Tetanus (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various…
Tetanus-Pipeline Review H1 2017
ReportsWeb.com has announced the addition of the “Tetanus-Pipeline Review H1 2017” this report provides an overview of the Tetanus-Pipeline landscape.
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Tetanus - Pipeline Review, H1 2017, provides an overview of the Tetanus (Infectious Disease) pipeline landscape.
Tetanus is a serious illness caused by Clostridium bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles, difficulty swallowing, stiffness of abdominal muscles, fever,…
World Diphtheria Treatment Market by Tetanus Immune Globulin, Tetanus Toxoid, Te …
The Global Diphtheria Treatment Market report titled “Diphtheria Treatment Market Research Report- Global Forecast Till 2023” is competitive analysis report summarizes historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/3828 .
Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheria causing severe sore throat and fever…
